COMPASS identifies T-cell subsets correlated with clinical outcomes - Test2 - elhamkhani - TriplyDB

COMPASS identifies T-cell subsets correlated with clinical outcomes

COMPASS identifies T-cell subsets correlated with clinical outcomes

http://www.wikidata.org/entity/Q27314516

about

Immune correlates of vaccine protection against HIV-1 acquisition Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study Systems serology for evaluation of HIV vaccine trials.Diagnostic Flow Cytometry and the AIDS Pandemic.Modeling HIV vaccine trials of the future.Current views on the potential for development of a HIV vaccine.Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Immune correlates for dengue vaccine development Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents.Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?Polyfunctional and IFN-γ monofunctional human CD4+ T cell populations are molecularly distinct.CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets.Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.HIV-specific Th2 and Th17 responses predict HIV vaccine protection efficacy.Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.Prospecting for an HIV vaccine.RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial.A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.Quantitative analyses reveal distinct sensitivities of the capture of HIV-1 primary viruses and pseudoviruses to broadly neutralizing antibodies.A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis.Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine.Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.Safety and Immunogenicity of PENNVAX®-G DNA Prime Administered by Biojector® 2000 or CELLECTRA® Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA.Highlights from the HIV Research for Prevention Conference (R4P),: 17-21 October 2016, Chicago, IL, USA.Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine.Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged ≥50 Years.High-resolution definition of humoral immune response correlates of effective immunity against HIV.

P2860

Q26778573-BB9ED51D-9653-4885-A39C-619B0478C339 Q28603191-FA72DE04-16F6-41F9-A37D-F5B5DA6ECB3E Q30238729-A472CF0C-0481-4D62-9A91-3BDA15090126 Q30378038-7EBF4ACB-E684-477D-80EF-E90F547FD37E Q30393307-62BEDFEF-45FE-40F6-839E-A7DFEF2ADFBE Q30397595-CD058116-226A-41C2-A42C-A4F6F26AFE18 Q33574027-6D28E87A-F824-4933-8691-092D38E39250 Q33683355-A3218555-6197-4B4E-AD89-8D5E97EDD190 Q33712296-0CD86246-A180-4FDF-B2C3-27199D609561 Q33745104-3EA60E15-F257-4F94-AE62-62C901C2A830 Q33924674-69663D54-18A5-47B5-8F98-14676B0260A2 Q35989484-827AF586-6AFA-40BF-B4DC-A35A3092BC26 Q36119504-FB5B7DC2-289A-46B7-9EDE-DB9EB5D398A5 Q36260275-F3DF5E3B-A7AE-4145-A10E-F47E316B6428 Q37597931-17C014AA-DE30-4B42-A319-EEDC9EE96718 Q37624370-0A4F17F3-B6D9-4949-81A0-59F89C828452 Q38701329-D03F6AA6-447F-46FC-916C-99EA955B956D Q38716886-07FDAD06-77FE-45DB-9585-F65996B8FB43 Q39045080-5F8A5E38-4301-4C10-B048-34BFBDE1827A Q39108730-956831BD-4F8E-44AC-8FFE-A0C85D2031BA Q39108779-706F035F-2D85-431F-A57E-DC0694B7A4F3 Q39393679-DAD663AF-F67F-4A35-9D56-4A600C3F31C1 Q39669371-AD2DC91E-7FB8-45AB-8FDA-CE1F1420C0F5 Q40042419-B72CD03D-1526-4C52-966D-8FC432263011 Q40051921-1DA80783-F4A2-4E54-90C0-4131CB79BE67 Q40054719-B52508A1-7231-4A9C-938A-8BAA675476D3 Q40061333-4ADE7F44-12BF-408F-9CA4-1A8AC008FDD9 Q40174154-D672F0FA-A6AA-4A9E-9A6B-52991EA871A0 Q40229934-4F4287C5-A2F5-416D-93A5-A6F89E525545 Q40332276-EF838410-2B73-44CE-8316-670EE3218F87 Q41697005-5DEAAD58-779E-45A0-ADF1-8445FEEACDC8 Q41918753-A1669955-F668-4410-9579-628D902F3B83 Q41926056-5416EF9F-7206-475B-B8B5-855BD47C9C63 Q41926555-026AF1D1-48CF-4337-B87A-9886C4162690 Q41995910-561BA5B5-C582-4AA9-A4FF-FA22EA550509 Q42365531-78E66FA1-1FEC-42B9-A0B3-4D694221E0F8 Q44168441-0C1FA800-CD73-4BE1-9373-B67BA2E42973 Q52561260-503F4B6F-D8CF-41E7-9F1E-C9271A79FB6B Q52727148-CEB021B7-4719-4988-BFE4-DA23E96CDC7B Q55022148-E0DC0C5B-839E-4BC5-A304-BC48448982D6

P2860

COMPASS identifies T-cell subsets correlated with clinical outcomes

http://www.wikidata.org/entity/Q27314516

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

COMPASS identifies T-cell subsets correlated with clinical outcomes

@ast

COMPASS identifies T-cell subsets correlated with clinical outcomes

@en

COMPASS identifies T-cell subsets correlated with clinical outcomes

@nl

type

label

COMPASS identifies T-cell subsets correlated with clinical outcomes

@ast

COMPASS identifies T-cell subsets correlated with clinical outcomes

@en

COMPASS identifies T-cell subsets correlated with clinical outcomes

@nl

prefLabel

COMPASS identifies T-cell subsets correlated with clinical outcomes

@ast

COMPASS identifies T-cell subsets correlated with clinical outcomes

@en

COMPASS identifies T-cell subsets correlated with clinical outcomes

@nl

P1433

Q27314516-D559A5B8-4291-4108-824A-AB3BDF61B1DB

P1476

Q27314516-3F2BE47A-CAB8-4066-AF69-C6E392EE6664

P2093

Q27314516-05D7772C-8969-49AD-B425-5102E060BC2E

Q27314516-17D07D4E-F366-403F-8D1A-97D986CA7EA7

Q27314516-3EB9D420-3E15-4321-A8FD-BAFF1DCA86D6

Q27314516-54F8257E-D8BE-4AB1-9A7A-25B8CD21DC3D

Q27314516-64753751-F8F6-4887-A35D-D90ED9D75D45

Q27314516-88C9F9CE-05AA-4BCE-A710-FB7207E5A430

Q27314516-A7C77431-4862-4181-9349-BD143F1DF9A1

Q27314516-A9521A36-0E4E-416D-8496-1A9E4D8F6951

Q27314516-B1374098-F761-4449-B75D-78831F364876

Q27314516-B30D006B-B26D-42CA-AB88-06F71BC36E34

P2860

Q27314516-075A10D5-60AE-43A1-9FA2-0732EB92B7B0

Q27314516-0BBC5755-9055-4030-B764-7226359B0988

Q27314516-1C201EED-ED98-4DBE-8845-7EA42C5FF387

Q27314516-2E5FFEE6-0EB8-43A6-B514-DB75E6611F2B

Q27314516-3005D946-E3C3-4AC3-9169-E170D23EEDDE

Q27314516-304B6175-18B5-48B7-830D-3CC4F00253E9

Q27314516-3765A6CA-4BE5-494A-917E-10DC9C14C006

Q27314516-37FA2C08-2131-405E-80BD-80EA7354BCC0

Q27314516-3A35F40B-F695-4566-9B2D-4D427926CE01

Q27314516-3A7EC288-4CB4-43D0-BA9D-ED4AA749E00F

P2888

Q27314516-0FC9EF2E-DAA7-4001-8662-501845B1943E

P304

Q27314516-40C91C09-A47C-4F86-B8A6-0934260464BE

P31

Q27314516-BC31795F-91DE-46E1-8E94-D612F1B2F180

P3181

Q27314516-84099DE7-3A1B-4B1F-ACB4-32A1126E1067

P356

Q27314516-5022F416-D7E6-4F51-AAA5-CC18ABFB0AE0

P407

Q27314516-144A66B4-2935-47ED-8A5B-476D62856070

P433

Q27314516-6AC95CDC-9DE4-40D1-881B-D8CF00B4D982

P478

Q27314516-2719DA90-2754-4195-B6A1-C4CF7C7374F9

P50

Q27314516-0B0611E6-9E8B-416B-8D58-525E2F53DD33

Q27314516-14A24970-90BF-4D0B-8442-394E5D329932

Q27314516-2FAF69D5-1C2C-46B9-9EF0-5F9B65767E8D

Q27314516-38BC7835-3751-47D3-B681-9C3D1EC695E2

Q27314516-3E24282D-2732-4281-A880-99D3158D883A

Q27314516-775B5820-54DA-4640-ABBF-CF6E416CAB2B

Q27314516-79C2504B-B5BB-413E-A23F-3CD72E8481AE

Q27314516-93FE512C-47D5-4130-95D5-838366FD91DE

Q27314516-B4201083-147B-41CA-842C-29307970CA99

Q27314516-C9579399-0B8D-46AC-A1FF-FBD07C1DC59D

P577

Q27314516-D9720A71-420C-4F3C-A973-8F73AEA8F975

P6179

Q27314516-4484A99F-F261-4CB7-8D97-2BACA5362B63

P698

Q27314516-B7428A23-B589-4353-96F7-16A0D18BA3C6

P921

Q27314516-3B1E8EA1-753A-43E6-A96D-DC4281EE8B54

Q27314516-8BE1F2F4-8038-42DB-A6C0-5848BFAC6409

Q27314516-8BFAC147-49CD-4827-A37F-9A8C1AB23151

P932

Q27314516-1A3CDED9-830F-433F-B754-C2F64BC08BBA

P3181

P356

P1433

Nature Biotechnology

P1476

COMPASS identifies T-cell subsets correlated with clinical outcomes

@en

P2093

Chetan Seshadri

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Hassan Mahomed

http://www.w3.org/2001/XMLSchema#string

Kevin Ushey

http://www.w3.org/2001/XMLSchema#string

Nicole Frahm

http://www.w3.org/2001/XMLSchema#string

Nicos Karasavvas

http://www.w3.org/2001/XMLSchema#string

Peter Gilbert

http://www.w3.org/2001/XMLSchema#string

Pierre-Alexandre Bart

http://www.w3.org/2001/XMLSchema#string

Punnee Pitisuttithum

http://www.w3.org/2001/XMLSchema#string

Raphael Gottardo

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Critical assessment of automated flow cytometry data analysis techniques.

Automated gating of flow cytometry data via robust model-based clustering.

Evaluating cellular polyfunctionality with a novel polyfunctionality index.

Induction of immunity to human immunodeficiency virus type-1 by vaccination.

SPICE: exploration and analysis of post-cytometric complex multivariate datasets

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

P2888

P304

610-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

616780

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NBT.3187

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Jaranit Kaewkungwal

Willem Albert Hanekom

Thomas J Scriba

Giuseppe Pantaleo

P577

2015-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024163754

http://www.w3.org/2001/XMLSchema#string

P698

26006008

http://www.w3.org/2001/XMLSchema#string

P921

P932

4569006

http://www.w3.org/2001/XMLSchema#string